Swedish pharma exports rise dramatically

5 September 2022
sweden_large

Pharma exports from Sweden have increased sharply during the first half of this year, figures show.

They amounted to approximately 70 billion Swedish kronor ($6.5 billion), compared to 50 billion kronor in the first half of 2021, according to Statistics Norway (SCB), the neighboring country’s bureau for stats.

This is an increase of 38% in economic value. The rise in volume was 34%, which is the highest increase among all export goods.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical